Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer

por House, Carrie Danielle, Hernandez, Lidia, Annunziata, Christina Messineo
Publicado 2014

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

por House, Carrie D., Hernandez, Lidia, Annunziata, Christina M.
Publicado en J Vis Exp (2015)

Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation

por Hernandez, Lidia, Kozlov, Serguei, Piras, Graziella, Stewart, Colin L.
Publicado 2003

Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism

por Hernandez, Lidia F., Dull, Angie B., Korrapati, Soumya, Annunziata, Christina M.
Publicado en Cell Death Discov (2021)

Ciclovia in a Rural Latino Community: Results and Lessons Learned

por Perry, Cynthia K., Ko, Linda K., Hernandez, Lidia, Ortiz, Rosa, Linde, Sandra
Publicado en J Public Health Manag Pract (2017)

Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation

por Cheng, Jr-Gang, Chen, Jim Ray, Hernandez, Lidia, Alvord, W. Greg, Stewart, Colin L.
Publicado 2001

Activation of NF-κB signaling by IKKβ increases aggressiveness of ovarian cancer

por Hernandez, Lídia, Hsu, Sarah, Davidson, Ben, Birrer, Michael J., Kohn, Elise C., Annunziata, Christina M.
Publicado 2010

IKKε coordinates invasion and metastasis of ovarian cancer

por Hsu, Sarah, Kim, Marianne, Hernandez, Lidia, Grajales, Valentina, Noonan, Anne, Anver, Miriam, Davidson, Ben, Annunziata, Christina M.
Publicado 2012

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer

por Kim, Marianne K., Caplen, Natasha, Chakka, Sirisha, Hernandez, Lidia, House, Carrie, Pongas, Georgios, Jordan, Elizabeth, Annunziata, Christina M.
Publicado en BMC Cancer (2016)

The small molecule NSC676914A is cytotoxic and differentially affects NFκB signaling in ovarian cancer cells and HEK293 cells

por Sagher, Ethan, Hernandez, Lidia, Heywood, Callee, Pauly, Gary T, Young, Matthew R, Schneider, Joel, Colburn, Nancy H, Annunziata, Christina M
Publicado 2014

Dysfunctional Connections Between the Nucleus and the Actin and Microtubule Networks in Laminopathic Models

por Hale, Christopher M., Shrestha, Arun L., Khatau, Shyam B., Stewart-Hutchinson, P. J., Hernandez, Lidia, Stewart, Colin L., Hodzic, Didier, Wirtz, Denis
Publicado 2008

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

por Hernandez, Lidia, Kim, Marianne K., Lyle, L. Tiffany, Bunch, Kristen P., House, Carrie D., Ning, Franklin, Noonan, Anne M., Annunziata, Christina M.
Publicado en Gynecol Oncol (2016)

Proteomic analysis of Escherichia coli detergent-resistant membranes (DRM)

por Guzmán-Flores, José E., Steinemann-Hernández, Lidia, González de la Vara, Luis E., Gavilanes-Ruiz, Marina, Romeo, Tony, Alvarez, Adrián F., Georgellis, Dimitris
Publicado en PLoS One (2019)

Zac1 (Lot1), a Potential Tumor Suppressor Gene, and the Gene for ɛ-Sarcoglycan Are Maternally Imprinted Genes: Identification by a Subtractive Screen of Novel Uniparental Fibroblas...

por Piras, Graziella, El Kharroubi, Aboubaker, Kozlov, Serguei, Escalante-Alcalde, Diana, Hernandez, Lidia, Copeland, Neal G., Gilbert, Debra J., Jenkins, Nancy A., Stewart, Colin L.
Publicado 2000

NF-κB transcription factors are co-expressed and convey poor outcome in ovarian cancer

por Annunziata, Christina M., Stavnes, Helene Tuft, Kleinberg, Lilach, Berner, Aasmund, Hernandez, Lidia F., Birrer, Michael J., Steinberg, Seth M., Davidson, Ben, Kohn, Elise C.
Publicado 2010

A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression

por Annunziata, Christina M., Hernandez, Lidia, Davis, R. Eric, Zingone, Adriana, Lamy, Laurence, Lam, Lloyd T., Hurt, Elaine M., Shaffer, Arthur L., Kuehl, W. Michael, Staudt, Louis M.
Publicado 2011

NF-kB promotes ovarian tumorigenesis via classical pathways that support proliferative cancer cells and alternative pathways that support ALDH+ cancer stem-like cells

por House, Carrie D., Jordan, Elizabeth, Hernandez, Lidia, Ozaki, Michelle, James, Jana M., Kim, Marianne, Kruhlak, Michael J., Batchelor, Eric, Elloumi, Fathi, Cam, Margaret C., Annunziata, Christina M.
Publicado en Cancer Res (2017)

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer

por Noonan, Anne M., Cousins, Amanda, Anderson, David, Zeligs, Kristen P., Bunch, Kristen, Hernandez, Lidia, Shibuya, Yusuke, Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig J., Annunziata, Christina M.
Publicado en Cancers (Basel) (2020)

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model

por Harrington, Brittney S., Ozaki, Michelle K., Caminear, Michael W., Hernandez, Lidia F., Jordan, Elizabeth, Kalinowski, Nicholas J., Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig, Shetty, Jyoti, Tran, Bao, Wong, Nathan, House, Carrie D., Annunziata, Christina M.
Publicado en Cancers (Basel) (2020)

Pathway-Specific Engineered Mouse Allograft Models Functionally Recapitulate Human Serous Epithelial Ovarian Cancer

por Szabova, Ludmila, Bupp, Sujata, Kamal, Muhaymin, Householder, Deborah B., Hernandez, Lidia, Schlomer, Jerome J., Baran, Maureen L., Yi, Ming, Stephens, Robert M., Annunziata, Christina M., Martin, Philip L., Van Dyke, Terry A., Ohler, Zoe Weaver, Difilippantonio, Simone
Publicado 2014